Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M416Revenue (TTM) $M121Net Margin (%)-19.1Altman Z-Score-11.2
Enterprise Value $M401EPS (TTM) $-0.1Operating Margin %-15.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-19.8Higher ROA y-yY
Price/Book12.110-y EBITDA Growth Rate %-33.9Quick Ratio1.7Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %-30.0Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-11.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-95.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M317ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARNA is held by these investors:



ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Munshi AmitPresident and CEO 2017-05-12Buy25,000$1.1910.08view
Munshi AmitPresident and CEO 2017-04-26Buy50,000$1.41-7.09view
White Christine AnnaDirector 2016-06-13Sell18,728$1.99-34.17view
WOODS RANDALL EDirector 2015-03-30Sell76,268$4.49-70.82view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-73.8view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-79.07view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-76.14view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-77.61view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-77.61view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-81.42view

Press Releases about ARNA :

Quarterly/Annual Reports about ARNA:

News about ARNA:

Articles On GuruFocus.com
Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of Pulmonary Arterial Hyper May 16 2017 
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results May 09 2017 
Arena Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update o May 02 2017 
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full o Apr 21 2017 
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Apr 17 2017 
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock Apr 17 2017 
Arena Pharmaceuticals Announces Multiple Presentations at ASPET 2017 at Experimental Biology Apr 17 2017 
Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter and Full-Year 2016 Fina Mar 06 2017 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
(ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 

More From Other Websites
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARNA-US : May... May 26 2017
5 Reasons Why VIVUS (VVUS) Stock Should Be in Your Portfolio May 24 2017
2 Marijuana Stocks That Rocketed Higher by a Double-Digit Percentage Last Week May 23 2017
Can This Struggling Biotech Become the Next Great Marijuana Stock? May 22 2017
Today's Research Reports on Biotech Stocks to Watch: Arena Pharmaceuticals and GlycoMimetics May 22 2017
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Today May 19 2017
Arena Pharmaceuticals to Host Key Opinion Leader Event on Pulmonary Arterial Hypertension (PAH) on... May 18 2017
Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of Pulmonary Arterial... May 16 2017
Edited Transcript of ARNA earnings conference call or presentation 9-May-17 8:30pm GMT May 16 2017
Arena Pharmaceuticals (ARNA) Posts Q1 Loss, Revenues Down May 10 2017
Arena Pharmaceuticals reports 1Q loss May 09 2017
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results May 09 2017
Investor Network: Arena Pharmaceuticals, Inc. to Host Earnings Call May 09 2017
Arena Pharmaceuticals (ARNA) Q1 Earnings: What's in Store? May 04 2017
Arena Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update... May 02 2017
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full... Apr 21 2017
Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : April 19, 2017 Apr 19 2017
Arena Pharma (ARNA) Down After Underwritten Public Offering Apr 19 2017
Biotech Industry Outperforming Major Indexes in 2017: Today's Research Reports on Arena... Apr 19 2017
Why Is Arena Pharmaceuticals (ARNA) Down 11.3% Since the Last Earnings Report? Apr 19 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)